IQ EQ Fund Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.43M Buy
50,840
+6,500
+15% +$173K 0.11% 170
2025
Q4
$1.1M Sell
44,340
-62,848
-59% -$1.58M 0.08% 204
2025
Q3
$2.73M Sell
107,188
-1,500
-1% -$37K 0.19% 134
2025
Q2
$2.63M Hold
108,688
0.23% 119
2025
Q1
$2.75M Sell
108,688
-149,622
-58% -$3.92M 0.32% 87
2024
Q4
$6.85M Buy
258,310
+1,850
+0.7% +$50.2K 0.81% 28
2024
Q3
$7.42M Buy
256,460
+23,928
+10% +$698K 0.77% 29
2024
Q2
$6.51M Sell
232,532
-500
-0.2% -$13.8K 0.74% 34
2024
Q1
$6.47M Sell
233,032
-2,100
-0.9% -$58.3K 0.73% 40
2023
Q4
$6.77M Buy
235,132
+129,225
+122% +$3.91M 0.8% 28
2023
Q3
$3.51M Buy
105,907
+2,762
+3% +$97.7K 0.72% 52
2023
Q2
$3.78M Buy
103,145
+1,196
+1% +$46.6K 0.72% 51
2023
Q1
$4.16M Buy
101,949
+1,768
+2% +$76.4K 0.8% 46
2022
Q4
$5.13M Sell
100,181
-13,730
-12% -$658K 1.05% 27
2022
Q3
$4.99M Sell
113,911
-2,678
-2% -$130K 1.12% 22
2022
Q2
$6.11M Buy
116,589
+603
+0.5% +$30.7K 1.21% 22
2022
Q1
$6M Sell
115,986
-798
-0.7% -$41.4K 0.98% 30
2021
Q4
$6.9M Sell
116,784
-7,440
-6% -$369K 1.06% 27
2021
Q3
$5.34M Sell
124,224
-5,180
-4% -$229K 0.82% 35
2021
Q2
$5.07M Sell
129,404
-2,735
-2% -$106K 0.78% 39
2021
Q1
$4.79M Buy
132,139
+3,325
+3% +$118K 0.84% 24
2020
Q4
$4.74M Sell
128,814
-4,796
-4% -$176K 1.1% 16
2020
Q3
$4.65M Sell
133,610
-3,799
-3% -$133K 1.39% 16
2020
Q2
$4.26M Sell
137,409
-805
-0.6% -$27.3K 1.43% 15
2020
Q1
$4.28M Sell
138,214
-5,032
-4% -$171K 1.75% 14
2019
Q4
$5.33M Sell
143,246
-2,967
-2% -$106K 1.69% 13
2019
Q3
$4.98M Sell
146,213
-3,183
-2% -$116K 1.61% 14
2019
Q2
$6.14M Buy
+149,396
New +$5.93M 1.98% 10
2018
Q4
$6.55M Sell
158,092
-51,186
-24% -$2.12M 2.4% 8
2018
Q3
$9.12M Sell
209,278
-84,766
-29% -$3.26M 2.5% 6
2018
Q2
$10.1M Buy
+294,044
New +$10M 2.71% 7
2017
Q1
$16.3M Sell
442,962
-9,873
-2% -$311K 3.05% 13
2016
Q4
$16M Buy
452,835
+2,238
+0.5% +$68.3K 2.91% 13
2016
Q3
$15.6M Buy
450,597
+12,148
+3% +$406K 2.88% 11
2016
Q2
$15.9M Sell
438,449
-36,828
-8% -$1.18M 3% 11
2016
Q1
$14.2M Sell
475,277
-34,785
-7% -$994K 2.59% 11
2015
Q4
$17.4M Sell
510,062
-218,245
-30% -$6.87M 2.98% 10
2015
Q3
$23.5M Sell
728,307
-17,713
-2% -$568K 3.8% 4
2015
Q2
$25.8M Buy
746,020
+83,448
+13% +$2.72M 3.71% 4
2015
Q1
$24.6M Sell
662,572
-67,823
-9% -$2.16M 3.3% 9
2014
Q4
$21.6M Buy
+730,395
New +$20.9M 3.13% 10

Other funds holding PFE

IQ EQ Fund Management's PFE Position: Q1 2026 in Review

IQ EQ Fund Management increased its Pfizer (PFE) stake by 15% in Q1 2026, buying an estimated $173K and bringing the position to 50,840 shares worth $1.43M. The position accounts for 0.11% of the portfolio, ranked #170.

IQ EQ Fund Management first reported a position in PFE in Q4 2014 and has held it in 41 quarters since. The position peaked at $25.8M in Q2 2015. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • IQ EQ Fund Management held 50,840 shares of Pfizer worth $1.43M as of Q1 2026.
  • IQ EQ Fund Management bought 6,500 Pfizer shares in Q1 2026, an estimated $173K.
  • Pfizer made up 0.11% of IQ EQ Fund Management's portfolio in Q1 2026, its #170 holding.
  • IQ EQ Fund Management first reported a position in Pfizer in Q4 2014 and has held it in 41 quarters since.
  • IQ EQ Fund Management's Pfizer position peaked at $25.8M in Q2 2015.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on IQ EQ Fund Management's 13F filing for Q1 2026, filed 11 May 2026.